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ABSTRACT
Objective: Alternative activation (M2) of adipose tissue resident macrophage (ATM) inhibits obesity-induced metabolic inﬂammation. The un-
derlying mechanisms remain unclear. Recent studies have shown that dysregulated lipid homeostasis caused by increased lipolysis in white
adipose tissue (WAT) in the obese state is a trigger of inﬂammatory responses. We investigated the role of M2 macrophages in lipotoxicity-
induced inﬂammation.
Methods: We used microarray experiments to proﬁle macrophage gene expression regulated by two M2 inducers, interleukin-4 (Il-4), and
peroxisome proliferator-activated receptor delta/gamma (Ppard/Pparg) agonists. Functional validation studies were performed in bone marrow-
derived macrophages and mice deprived of the signal transducer and activator of transcription 6 gene (Stat6; downstream effector of Il-4) or
Ppard/Pparg genes (downstream effectors of Stat6). Palmitic acid (PA) and b-adrenergic agonist were employed to induce macrophage lipid
loading in vitro and in vivo, respectively.
Results: Proﬁling of genes regulated by Il-4 or Ppard/Pparg agonists reveals that alternative activation promotes the cell survival program, while
inhibiting that of inﬂammation-related cell death. Deletion of Stat6 or Ppard/Pparg increases the susceptibility of macrophages to PA-induced cell
death. NLR family pyrin domain containing 3 (Nlrp3) inﬂammasome activation by PA in the presence of lipopolysaccharide is also increased in
Stat6/ macrophages and to a lesser extent, in Ppard/g/ macrophages. In concert, b-adrenergic agonist-induced lipolysis results in higher
levels of cell death and inﬂammatory markers in ATMs derived from myeloid-speciﬁc Ppard/g/ or Stat6/ mice.
Conclusions: Our data suggest that ATM cell death is closely linked to metabolic inﬂammation. Within WAT where concentrations of free fatty
acids ﬂuctuate, M2 polarization regulated by the Stat6-Ppar axis enhances ATM’s tolerance to lipid-mediated stress, thereby maintaining the
homeostatic state.
 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. INTRODUCTION
Obesity and related metabolic syndrome are major medical and eco-
nomic burdens worldwide. Chronic low-grade inﬂammation is often
observed in obesity and is a key contributor to associated pathologies
such as insulin resistance, type 2 diabetes, and atherosclerosis [1e3].
White adipose tissue (WAT) is a primary energy storing tissue that has
been recognized as an important endocrine organ modulating
metabolic-related inﬂammation (or meta-inﬂammation) through
crosstalk with resident immune cells, such as macrophages and
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lymphocytes. In lean individuals, adipose tissue macrophages (ATMs)
have an alternatively activated (M2) phenotype that limits inﬂammation
and sustains homeostasis [1,3]. With the onset of obesity, classically
activated M1 macrophages preferentially accumulate in WAT and
exhibit a pro-inﬂammatory phenotype characterized by the production
of cytokines such as interleukin-1b (Il-1b) and tumor necrosis factor-a
(Tnf-a) [1e3]. These M1 derived pro-inﬂammatory mediators have
been shown to cause metabolic dysregulation and insulin resistance
[1e3]. While this M1/M2 paradigm is instrumental for describing
immune phenotypes in physiological and pathological states, recent
studies have implicated a dynamic and complex ATM polarization
process [4]. In addition, it has been shown that metabolically activated
macrophages driven primarily by free fatty acids (FA) do not express
M1 surface markers, despite increased production of Il-1b and Tnf-a
in these cells [5].
Several stimuli from the adipose microenvironment have been reported
to regulate the ATM phenotype. It has been suggested that at the lean
state, eosinophils and type 2 innate lymphoid cells (ILC2s) constitu-
tively produce Th2 cytokines interleukin-4 (Il-4) and interleukin-13 (Il-
13), respectively, which promote M2 polarization [6,7]. In the patho-
logical context of obesity, adipocyte hypertrophy and cell death in-
crease the production of chemokines, such as C-X-C motif chemokine
ligand 12 (Cxcl12) and monocyte chemotactic protein-1 (Mcp-1) to
recruit Ly6ChiCcr2þ monocytes into WAT [8,9], where CD8þ cytotoxic
T cells have been found to secrete interferon-g (Ifn-g) that contributes
to macrophage M1 polarization [3,10,11]. In addition to the classical
M1 activation, dysregulated lipid homeostasis caused by increased
lipolysis in WAT has also been shown to be a trigger of inﬂammatory
responses in ATMs as described above. Recent studies have
demonstrated that saturated FA and their metabolites, notably
ceramides, can act on NLR family pyrin domain containing 3 (Nlrp3)
inﬂammasome formation, resulting in autocatalytic activation of
caspase-1 and production of mature Il-1b to promote inﬂammation
[12,13]. Interestingly, WAT lipolysis by fasting or b-adrenergic stim-
ulation can also drive ATM accumulation in lean individuals [14]. This
raises the question of how M2 ATMs regulate FA-induced immune
responses.
Macrophage M2 polarization requires activation and cooperation of
several transcriptional factors [3,15]. Signal transducer and activator of
transcription 6 (Stat6), the canonical effector of Th2 signaling, has
been proposed to regulate mitochondrial oxidative metabolism to fuel
M2 activation [3,15,16]. In mice, Stat6 controls the expression of
nuclear receptors peroxisome proliferator-activated receptor delta
(Ppard or Pparb) and gamma (Pparg), both of which can further
modulate the function of M2 macrophages [9,17,18]. Ppard/Pparg are
well-known lipid sensing nuclear receptors. A variety of endogenous
lipids, including unsaturated FAs, saturated FAs and hydrox-
yeicosatetraenoic acids can physically bind to Ppard and Pparg, which,
in turn, activate the transcriptional programs for FA oxidation, mito-
chondrial biogenesis, and anti-inﬂammatory response in macrophages
[15,19]. Stat6/, myeloid-Ppard/, and myeloid-Pparg/mice are
more prone to high fat diet induced WAT inﬂammation and insulin
resistance [17,20e22]. The metabolic function of the Stat6-Ppar
signaling cascade implicates a role for M2 macrophages in medi-
ating FA homeostasis within WAT.
The current study aims to identify potential physiological functions
of M2 polarization in ATMs. Through expression proﬁling and ge-
netic approaches, we ﬁnd that the Stat6-Ppar axis plays an
important role in protecting macrophages against lipotoxicity-
induced cellular dysfunction. This is mediated by transcriptional
regulation of cell death/pro-survival genes, in addition to their
known function in FA metabolism and mitochondrial respiration.
Dysregulation of M2 signaling, such as in Stat6/ and Ppard/
Pparg/ macrophages, increases susceptibility to palmitic acid
(PA)-induced cell death, which contributes to the initiation of
metabolic inﬂammation in WAT.
2. MATERIALS AND METHODS
2.1. Animal experiments
2.1.1. Mouse models
Stat6/ mice and the C57BL/6J controls as well as lysozyme-cre
mice were purchased from the Jackson Laboratory (Bar Harbor, ME,
USA). Ppardf/f and Ppargf/f in the C57BL/6J background were gener-
ated as described previously [23,24]. Ppard/gf/f mice were obtained by
crossing the Ppardf/f and Ppargf/f alleles. These mice were used to
create myeloid-speciﬁc Ppard/, Pparg/ and Ppard/g/ mice,
respectively (Mac-Ppard/, Mac-Pparg/ and Mac-Ppard/g/),
by crossing to lysozyme-cre. All mice were housed in a 12 h light/12 h
dark cycle with temperatures of 18e23 C and 40e60% humidity on
standard chow diet and allowed food and water ad libitum unless
otherwise stated. Mice were sacriﬁced by CO2 asphyxiation. All animal
studies were approved by the Harvard Medical Area Standing Com-
mittee on Animals.
2.1.2. Metabolic studies
In vivo studies were conducted in 3-month-old male mice on normal
chow diet (n ¼ 4e7). After 14 h fasting, animals were injected
intraperitoneally with 1 mg/kg of CL316,243 (Santa Cruz Biotech-
nology, Dallas, TX, USA, Cat# sc-203895) or saline and sacriﬁced 2.5 h
after injection.
2.1.3. Stromal vascular fraction (SVF) and ATMs isolation
For SVF isolation, perigonadal adipose tissue was excised and digested
with digestion buffer (DMEM, 1 g/L glucose, 2 mg/ml collagenase type
II and 2% albumin) at 37 C for 30 min [17]. After ﬁltering through
250 mm nylon mesh, digested adipose tissue was spun down at 400 g
for 5 min. The supernatant was discarded and cells were resuspended
in washing buffer (DMEM, 1 g/L glucose and 2% albumin). After
ﬁltering through 70 mm ﬁlter, cells were spun down at 400 g for 5 min
and cell pellet was collected. Lysis buffer (150 mM NH4Cl, 1 mM
KHCO3, 0.1 mM EDTA, pH 7.2e7.4) was added for 5 min to remove
red blood cells. Cells were subsequently ﬁltered through 40 mm ﬁlter,
spun down, and collected for analysis.
For ATMs isolation, SVF was further incubated with an anti-F4/80
antibody (Invitrogen, Grand Island, NY, USA) for 30 min at 4 C. Af-
ter spinning down at 400 g for 5 min, SVF was resuspended in isolation
buffer (PBS, 0.1% BSA, 2 mM EDTA, pH 7.4) containing Dynabeads
(Invitrogen). After gently rotating for 30 min at 4 C, F4/80 positive
cells were selected by magnetic Dynabeads according to manufac-
turer’s protocol.
2.1.4. Blood sampling and analysis
Blood glucose measurements were performed using the One Touch
Ultra Blood Glucose Diabetic Test Strips (LifeScan, Milpitas, CA, USA).
For blood chemistry, blood samples were taken from mouse hearts
immediately after sacriﬁce and placed on ice for 30 min. Samples
were subsequently centrifuged at 2,000 g for 10 min to remove the
clot and serum was collected and store at 80 C for analysis.
Serum free FAs were measured using commercially kits from Wako
Chemicals (Richmond, VA, USA) and triglycerides (TG) were tested by
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Inﬁnity Triglycerides Reagents (Thermo Scientiﬁc, Waltham, MA,
USA).
2.2. Cell culture
2.2.1. Differentiation and maintenance of mouse macrophages
RAW 264.7 macrophages were maintained in DMEM (1 g/L glucose)
medium containing 10% FBS. For bone marrow-derived macrophages
(BMDMs), bone marrow was ﬂushed out in wash buffer (DMEM,1 g/L
glucose, 10% FBS). After spinning down, cell pellet was resuspended
in lysis buffer (150 mM NH4Cl, 1 mM KHCO3, 0.1 mM EDTA, pH 7.2e
7.4) for 10 min to remove red blood cells. Remaining cells were then
spun down and differentiated in differentiation medium (DMEM, 1 g/L
glucose, 10% FBS, 20% L929 condition medium) [25]. Differentiation
medium was replaced at day 3, 5, and 7. All experiments were ﬁnished
between day 7e9. Similar results were obtained from marrow cells of
male or female mice.
2.2.2. Treatment
Recombinant mouse Il-4 (rIl-4, 10 ng/ml, Peprotech, Rocky Hill, NJ,
USA), GW501516, GW0742 (0.1 mM for both, Cayman Chemical, Ann
Arbor, MI, USA), GW1929 (1 mM, Sigma, St. Louis, MO, USA), or vehicle
(DMSO for Ppar agonists) were incubated with macrophages overnight
in 10% FBS, DMEM. PA (Sigma) was prepared as previously described
[26] and added to cells at ﬁnal concentrations of 300 mM in 0.45%
BSA, 2% double stripped FBS, DMEM for 16 h. For PA-induced
inﬂammasome activation, lipopolysaccharide (LPS, 10 ng/ml, Sigma)
was pre-incubated with macrophages for 3 h in 10% FBS, DMEM
before the addition of PA.
2.3. Microarray and statistical analyses
For microarray analyses, samples were sent to the Yale Center for
Genome Analysis and hybridized to a NimbleGen Eukaryotic Gene
Expression 12  135 K microarray (Roche NimbleGen, Madison, WI,
USA). The microarray data are available at the Gene Expression
Omnibus database (https://www.ncbi.nlm.nih.gov/geo/) under sub-
mission number GSE100237. Log transformed, normalized intensity
for each sample was used for downstream analysis by MeV software
suite (http://mev.tm4.org/). Statistical signiﬁcance between treatment
groups was determined using the linear models for microarray (limma)
function within the MeV suite. Expression changes were considered
signiﬁcant with a nominal p value < 0.05 (see Supplementary
Table 1e3 for signiﬁcantly altered genes). Gene ontology over-
representation analysis and clustering of signiﬁcantly altered genes
were performed in DAVID (https://david.ncifcrf.gov/) [27,28] (see
Supplementary Tables 4 and 5 for gene lists). Heat maps were
generated by MultiExperiment Viewer.
Statistical analyses were performed using Student’s t test (two tailed).
Experiments were conducted with 3e4 replicates and repeated at
least three times. In vivo studies were conducted in two cohorts
(n ¼ 4e7 per treatment per genotype). Values were presented as
means  SEM. p < 0.05 was considered signiﬁcant.
2.4. Expression analyses and enzymatic assays
2.4.1. Real-time quantitative PCR (qPCR)
Total RNA was isolated from macrophages using PrepEase RNA Spin
Kit (Affymetrix, Santa Clara, CA, USA, Cat# 78767) according to
manufacturer’s protocol. Isolated RNA (1 mg) was reversed transcribed
into cDNA using Verso cDNA Synthesis Kit (Thermo Scientiﬁc, Cat# AB-
1453/B) according to manufacturer’s protocol. Quantitative PCR was
performed with SYBR green-based assays. 36b4 was used a loading
control. Expression of each gene transcript was calculated using a
relative standard and normalize to 36b4 [29]. The primers used for
qPCR were listed in Supplementary Table 6.
2.4.2. Caspase-3 activity/lactate dehydrogenase (LDH) release
Caspase-3 activity was measured with Caspase-Glo 3/7 Assay kits
(Promega, Madison, WI, USA). Lactate dehydrogenase (LDH) release
was determined with CytoTox 96 Non-Radioactive Cytotoxicity Assay
kits (Promega).
2.4.3. Flow cytometry
For ﬂow cytometry, BMDMs were collected and stained with Alexa
Fluor 647-conjugated anti-annexin-V antibody (Invitrogen, Cat.
#A35110) for 15 min on ice in dark. Cells were then transferred into
polystyrene test tubes and analyzed using FACS Caliber ﬂow cytometer
(BD Biosciences, San Jose, CA, USA). To determine ATM populations in
WAT, SVF was isolated and stained with APC-conjugated anti-F4/80
antibody (Invitrogen, Cat. #MF48005) and Alexa Fluor 488-conjugated
anti-annexin-V antibody (Invitrogen, Cat. #A13201) for 15 min on ice.
2.4.4. Immunoblotting
Protein samples were isolated from BMDMs using RIPA buffer con-
taining protease and phosphatase inhibitors. The extracted proteins
were frozen and stored at 80 C. The prepared proteins were sub-
sequently separated by SDS-PAGE and transferred on to membranes.
We used PVDF Transfer Membranes (Thermo Scientiﬁc, Cat# 88518)
for caspase-1 p45 and tubulin, and FluoroTrans PVDF Transfer
Membranes (Pall, Westborough, MA, USA, Cat# BSP0161) for caspase-
1 p10. Membranes were incubated in the primary antibodies overnight
at 4 C and HRP-conjugated secondary antibodies for 1 h at room
temperature. Tubulin was used as loading control. Antibody against
caspase-1 was purchased from Santa Cruz Biotechnology (Cat. #SC-
514) and tubulin was purchased from Cell Signaling Technology
(Danvers, MA, USA, Cat# 2128).
2.4.5. ELISA
Supernatants were collected from BMDMs after treatment, and Il-1b
concentrations were measured by using Il-1b ELISA kit (BD Bio-
sciences, Cat. #559603) according to manufacturer’s protocol.
2.5. Mitochondrial respiration
BMDMs were seeded in a 24-well holding plate (Seahorse Bioscience,
Billerica, MA, USA). After PA treatment, macrophages were washed 3
times with running medium (DMEM without phenol red supplemented
with 5 mM glucose and 1 mM sodium pyruvate pH 7.2e7.4) and
subsequently kept in 560 mL running medium in CO2 37 C incubator
for an hour. The basal oxygen consumption rate (OCR) was determined
on XF24 Seahorse extracellular ﬂux analyzer (Agilent, Santa Clara, CA,
USA).
2.6. FA oxidation
BMDMs were seeded in 6-well plates (Corning, NY, USA). After PA
treatment, cells were washed with PBS once and replaced with 1 ml
loading medium [DMEM, 1 g/L glucose and 2% BSA (Sigma, Cat. #A-
6003)] for 30 min. After washing with PBS once, cells were replaced
with 600 mL medium containing DMEM (1 g/L glucose), 2% BSA
(Sigma Cat. #A6003), 0.25 mM carnitine (Sigma, Cat. #C-0158) and 2
uCi 3H-palmitic acid (American radiolabeled chemicals, St. Louis, MO,
USA, Cat. #ART129) for 4 h. Supernatants were collected and the 3H
radioactivity in the aqueous phase was quantiﬁed as described [30].
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Figure 1: Pro-survival genes are up-regulated in alternatively activated macrophages. (A) List of top 10 DAVID functional annotation clusters for biological processes
signiﬁcantly altered by GW501516 or Il-4 treatment, compared to the vehicle control (see Supplementary Tables 4 and 5 for gene lists). Microarray analysis was conducted in
Ppard-overexpressing RAW 264.7 cells treated with GW501516 (0.1 mM) or rIl-4 (10 ng/ml) overnight. (B) Heat maps were shown for selected genes from the top 10 regulated
pathways (Figure 1A) by GW501516 (Ppard agonist, left) or Il-4 treatment (right) presented as fold change over vehicle control. (C) Validation of Ppar target genes identiﬁed through
microarray using qPCR in WT, Mac-Ppard/ and Mac-Ppard/g/ BMDMs treated with GW0742 (0.1 mM) overnight. (D) Validation of Il-4 regulated genes in WT and Stat6/
BMDMs incubated with rIl-4 (10 ng/ml) overnight. Values were expressed as means  SEM. #p < 0.05 between vehicle and GW0742 or rIl-4 treatment.




BMDMs were collected and lysed in lysis buffer [50 mM Tris (pH 8),
100 mM NaCl and 0.1% NP40]. After freezing and thawing 3 times,
cellular lipid was extracted with chloroform: methanol (2:1 v/v) as
described previously [31]. TG content was determined by Inﬁnity Tri-
glycerides Reagents (Thermo Scientiﬁc).
3. RESULTS
3.1. Cell survival is transcriptionally regulated by macrophage
alternative activation
ATMs exhibit a unique phenotypic transition from M2 to M1 activation
in the lean versus obese state. The Th2 cytokine-Stat6-Ppard/g axis
has previous been shown to maintain the M2 phenotype of ATMs
[3,15]. To better understand the physiological function of M2 ATMs, we
performed gene expression proﬁling using samples from RAW 264.7
cells stably overexpressing Ppard (RAW-Ppard) treated with vehicle,
GW501516 (a synthetic Ppard ligand), or Th2 cytokine Il-4 [see
Supplementary Table 1e3 for signiﬁcantly altered genes; original data
in Gene Expression Omnibus database #GSE100237 (https://www.
ncbi.nlm.nih.gov/geo/)]. DAVID functional annotation clustering ana-
lyses were employed to identify pathways signiﬁcantly altered by either
GW501516 or Il-4 treatment compared to vehicle control [27,28]. As
expected, GW501516 treatment led to enrichment of genes involved in
lipid metabolism as well as certain immune signaling (e.g., T cell
function), while Il-4 induced enrichment of genes related to Th2
response (e.g., major histocompatibility complex class II antigen pre-
sentation and lymphocyte activation) and eicosanoid synthesis
(Figure 1A and B and Supplementary Tables 4 and 5). Interestingly, cell
death was among the top 10 functional clusters enriched in either
GW501516 or Il-4 treatment group.
Selected genes from microarray results were ﬁrst validated in RAW-
Ppard cells treated with another Ppard agonist GW0742 or vehicle
control. GW0742 signiﬁcantly induced the expression of genes
involved in cell death [angiopoietin-like 4 (Angptl4) and sphingomyelin
synthase 1 (Sgms1)], lipid metabolism [perilipin 2 (Plin2, also called
adipocyte differentiation-related protein, Adrp), acyl-CoA dehydroge-
nase, very long chain (Acadvl), CD36 molecule (Cd36), solute carrier
family 25 member 20 (Slc25a20), and monoacylglycerol O-acyl-
transferase 1 (Mogat1)] and M2 markers [e.g., macrophage galactose-
type lectin-1 (Mgl1)], while inhibiting genes involved in inﬂammation
(e.g., Tnf-a) (Supplementary Figure 1A). In BMDMs from wild-type (WT)
mice, GW0742 signiﬁcantly increased the expression of genes iden-
tiﬁed by the microarray (e.g., Plin2, Angptl4, and Sgms1; Figure 1C).
These effects were completely abolished in BMDMs from Mac-Ppard/
g/ but not from Mac-Ppard/ mice, suggesting that GW0742 at
the dose used also activated Pparg and that Pparg shared common
target genes with Ppard. In concert, most of the Ppard-controlled
genes can also be regulated by Pparg (Supplementary Figure 1B). Il-4
treated RAW-Ppard cells showed signiﬁcant induction of cell survival
genes [insulin like growth factor 1 (Igf1), B-cell lymphoma 2 (Bcl2) and
Sgms1] and M2 markers [histocompatibility 2, class II antigen E beta
(H2-Eb1), Mgl1, Ym1 (also called chitinase-like 3, Chil3), and Arginase
1 (Arg1)], and reduced expression of pro-inﬂammatory genes (Tnf-a
and Nlrp3) (Supplementary Figure 1C). Similar regulation was observed
in BMDMs in a Stat6 dependent manner (Figure 1D).
3.2. Lipotoxicity-induced cell death is exacerbated in Ppard/g/
or Stat6/ macrophages
In obesity, increased free FAs released from insulin-resistant adipo-
cytes result in lipotoxicity [8]. Ceramides, derived from FAs can cause
cellular dysfunction at elevated concentrations, including cell death
and inﬂammasome activation [12,13]. Most of genes in the cell death
category identiﬁed by the array were suppressed by GW501516 or Il-4
treatment (Supplementary Figure 1D and Supplementary Tables 7 and
8). 19 of those commonly down-regulated genes in both treatments
included many cell death promoters, such as BCL2-like 13 (Bcl2l13)
and caspase recruitment domain family, member 9 (Card9). Sgms1
was one of the 6 up-regulated (presumably pro-survival) genes shared
by Ppard/g and Stat6 that converts ceramides to sphingomyelin and
has been shown to suppress Bcl2-associated X Protein (BAX)-medi-
ated apoptosis and prevent cell death induced by oxidative damage
[32,33]. To determine whether macrophage Ppars and Stat6 play a role
in handling lipid-induced toxicity, we challenged BMDMs with PA, one
of the most abundant FAs in the body. Flow cytometry assays showed
increased annexin-V positive Ppard/g/ and Stat6/ cells after 16 h
of PA treatment, compared to control cells (Figure 2A). There was a
two-fold increase in cell death determined by caspase-3 activity in
Ppard/g/ BMDMs, compared to WT cells (Figure 2B). Interestingly,
deletion of Ppard or Pparg alone in the macrophage was sufﬁcient to
promote PA-induced cell death (Supplementary Figure 2), suggesting
that both Ppard and Pparg are required to maintain lipid homeostasis.
Stat6/ BMDMs also showed signiﬁcantly increased caspase-3 ac-
tivity, compared to WT cells (Figure 2B). These results demonstrate
that macrophages lacking Ppard/g or Stat6 are more susceptible to
PA-induced cell death.
The Stat6/Ppar transcriptional cascade also regulates macrophage
lipid metabolism and mitochondrial function [9,15], which could limit
lipotoxicity by reducing lipid burden. PA treatment increased mito-
chondrial respiration determined by OCR in WT BMDMs, and this effect
was absent in Ppard/g/ cells (Figure 2C). Although the basal OCR of
Stat6/ macrophages was higher than that of WT cells as reported
previously [16], PA treatment suppressed, rather than enhanced
mitochondrial respiration in Stat6/ cells (Figure 2C). Similarly, FA-
induced b-oxidation was abolished in Ppard/g/ and Stat6/
BMDMs (Figure 2D), while intracellular TG content was elevated in
these cells (Figure 2E).
At the transcriptional level, PA induced expression of Plin2, a well-
deﬁned Ppar target gene in lipid droplet formation [34], was
completely abolished in Ppard/g/ macrophages (Figure 3A),
consistent with the notion that FAs serve as Ppar agonists. The
expression of cell survival genes (Angptl4, Sgms1, Bcl2) was also
induced by PA treatment in WT macrophages. This response was
blunted in Ppard/g/ and Stat6/ cells (Figure 3A and B).
We next sought to determine if activation of Ppars or Stat6 could
alleviate lipotoxicity-induced cell death. WT BMDMs were primed with
GW0742 or Il-4 overnight followed by 16 h of PA treatment. Both
GW0742 and Il-4 pretreatment signiﬁcantly reduced the percentages
of annexin-Vþ cells (Figure 3C). Collectively, these data suggest that
the Stat6-Ppard/g axis in the macrophage protects against lipotoxicity-
triggered cell death through regulation of genes involved in cell sur-
vival, in addition to mitochondrial function and FA metabolism.
3.3. Il-4-Stat6 signaling suppresses lipotoxicity-induced
inﬂammasome activation
Lipotoxicity-mediated inﬂammasome activation has emerged as a key
pathogenic contributor to WAT inﬂammation and its metabolic
sequelae [2]. Previous studies suggest PA and its metabolite ceramide
can cause NLRP3 inﬂammasome activation in LPS-primed macro-
phages [12,13]. Our microarray results indicated that expression of
inﬂammasome-related genes such as Nlrp3 were inhibited by Il-4
treatment (Figure 1B). Furthermore, qPCR in Raw 264.7 cells and
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Figure 2: PA-induced cellular dysfunction is exacerbated in Mac-Ppard/g/ and Stat6/ macrophages. (A) and (B) Cell death quantiﬁed by annexin-V staining using ﬂow
cytometry or by caspase-3 activity in BMDMs treated with PA (300 mM) for 16 h. (C) Mitochondrial OCR measured by Seahorse bioenergetic analyzer in BMDMs treated with PA
(300 mM) for 16 h (D) FA b-oxidation determined by using 3H-PA in control or PA-treated BMDMs. (E) Intracellular TG content in control or PA-treated BMDMs. Values were
expressed as means  SEM. *p < 0.05 between WT and Mac-Ppard/g/ or Stat6/; #p < 0.05 between vehicle and PA treatment.
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BMDMs has demonstrated that Il-4 treatment substantially down-
regulated Nlrp3 and its downstream effector Il-1b (Figure 1D and
Supplementary Figure 1C). Based on these observations, we tested if
Stat6-Ppar signaling modulates lipotoxicity-induced inﬂammasome
activation. WT, Ppard/g/ and Stat6/ BMDMs were primed with
LPS for 3 h followed by 16 h of LPS þ PA treatment. Cell lysates and
conditioned media were collected for analysis. Il-1b release in the
media determined by ELISA was signiﬁcantly increased after LPSþ PA
stimulation (Figure 4A). Ppard/g deﬁciency resulted in a moderate
increase in Il-1b release, while Stat6 disruption led tow10-fold higher
Figure 3: Alternative activation protects macrophages from lipotoxicity-induced cell death. (A) Gene expression determine by qPCR in WT and Mac-Ppard/g/ BMDMs
treated with vehicle or PA (300 mM) for 16 h. (B) Gene expression in WT and Stat6/ BMDMs  PA (300 mM) for 16 h (C) WT BMDMs were pre-incubated with GW0742 (0.1 mM)
or rIl-4 (10 ng/ml) overnight before the addition of PA (300 mM) for 16 h. Percentage of annexin-Vþ cells was measured by ﬂow cytometry. Values were presented as
means  SEM. *p < 0.05 between WT and Mac-Ppard/g/ or Stat6/; #p < 0.05 between vehicle and PA, GW0742 or rIl-4 treatment.
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Figure 4: Il-4-Stat6 signaling inhibits lipotoxicity-induced inﬂammasome activation. (AeC) WT, Mac-Ppard/g/ and Stat6/ BMDMs were treated with or without LPS
(10 ng/ml) for 3 h before the addition of PA (300 mM) for 16 h. (A) Supernatant Il-1b concentrations measured by ELISA. (B) Immunoblotting for activated p10 caspase-1 in
supernatant (Sup) and for unprocessed p45 caspase-1 and tubulin in cell lysates (Lys). Bottom panel: relative western signal of caspase-1 (p10) normalized to tubulin and shown as
fold change to vehicle treated WT sample (set as 1). Results were the average of three independent experiments. (C) LDH release in supernatant. (DeG) WT BMDMs were
pretreated with GW0742 (0.1 mM) or rIl-4 (10 ng/ml) overnight followed by PA or LPS þ PA treatment. (D) Expression of genes involved in inﬂammasome activation. (E) Supernatant
Il-1b concentrations. (F) Caspase-1 processing was measured by western blotting. Bottom panel: relative western signal of caspase-1 (p10) normalized to tubulin and shown as
fold change to vehicle treated control sample (set as 1). (G) Quantiﬁcation of LDH release in supernatants. Values were expressed as means  SEM. *p < 0.05 between WT and
Mac-Ppard/g/ or Stat6/; #p < 0.05 between vehicle and GW0742 or rIl-4 treatment.
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Il-1b production (Figure 4A). In line with this observation, the level of
cleaved caspase-1 (P10) was increased in Stat6/macrophages, and
to a lesser extent in Ppard/g/ macrophages, compared to WT
control (Figure 4B). Similar results were observed with the level of LDH
protein in the media, which serves as a marker for inﬂammasome-
induced cell death, or pyroptosis (Figure 4C). Reciprocally, activating
Stat6 in WT BMDMs through Il-4 pretreatment suppressed LPS þ PA-
induced Nlrp3 and Il-1b expression, Il-1b production, caspase-1
processing and LDH release (Figure 4DeG). Ppard/g activation by
GW0742 could also suppress inﬂammasome activation. However, the
effect was not as strong as Il-4 treatment (Figure 4DeG). These
ﬁndings provide a mechanistic explanation for how M2 activation in-
hibits metabolic inﬂammation.
3.4. Increased cell death in ATMs from macrophage-speciﬁc
Ppard/g/ or Stat6/ mice
Results described thus far implicate a critical role of Ppard/Pparg and
Stat6 in modulating macrophage survival ex vivo. To validate in vivo
functional relevance, mice were fasted for 14 h, followed by injection
with a b3-adrenergic agonist CL316,243 to induce lipolysis. The SVF
was isolated from perigonadal adipose tissue to assess the ATM
phenotype. CL316,243 treatment in fasted mice induced a w2-fold
increase in serum free FA levels (Table 1). Ppard/g depletion led to
an increase in macrophage inﬁltration in WAT demonstrated by higher
percentage of F4/80þ cells in SVF of CL316,243-injected Mac-Ppard/
g/ mice, and a trend towards an increase in macrophage inﬁltration
in vehicle (saline)-injected Mac-Ppard/g/ mice (Supplementary
Figure 3A). There was no difference in ATM caspase-3 activity be-
tween genotypes after 14 h fasting (Figure 5A, left panel). CL316,243
treatment led to increased caspase-3 activity in Mac-Ppard/g/
ATMs, compared to WT cells (Figure 5A, right panel). ATMs from Mac-
Ppard/g/ mice in both saline and CL316,243 injected groups had
reduced expression of FA metabolism, cell survival and M2 genes,
while pro-inﬂammatory genes (e.g., Il-1b and Tnf-a) were up-
regulated (Figure 5B and Supplementary Figure 3B). Consistent with
the increased caspase 3 activity, CL316,243 treatment further sup-
pressed survival genes, such as Sgms1 and Bcl2.
On the other hand, fasting-induced lipolysis was sufﬁcient to cause an
w60% increase in caspase-3 activity in Stat6/ ATMs compared to
WT control (Figure 5C left panel). This difference was exacerbated by
CL316,243 injection (Figure 5C right panel), which was accompanied
by a reduction in ATMs (Supplementary Figure 3C). As expected, Stat6
deﬁciency impaired macrophage M2 polarization, as evidenced by a
lower percentage of F4/80þMgl1þ population (data not shown) and
decreased Mgl1 expression in Stat6/ ATMs under control and
CL316,243 treatment, compared to WT ATMs (Figure 5D and
Supplementary Figure 3D). In contrast, inﬂammatory markers,
including Il-1b, Nlrp3, and Tnf-a, were up-regulated. CL316,243
treatment similarly exerted a greater effect on decreasing the
expression of Sgms1 and Bcl2 in Stat6/ ATMs (Figure 5D).
Furthermore, concentrations of fasting glucose and insulin were
signiﬁcantly higher in Stat6/ than in WT mice after CL316,243 in-
jection (Table 1). Altogether, these data suggest that an intact Stat6-
Ppard/g signaling is required for maintaining ATM homeostasis by
protecting macrophages against lipotoxicity-mediated cellular
dysfunction.
4. DISCUSSION
In this study, we describe a mechanism through which M2 polarization
protects macrophages from lipotoxicity-mediated cellular dysfunction
and consequently maintains adipose tissue homeostasis. Gene
expression proﬁling studies reveal that both Stat6 and Ppar signaling
up-regulates pro-survival genes while inhibiting inﬂammation-related
cell death pathways. Along this line, cell death triggered by elevated
free FA levels is exacerbated in Ppard/g/ and Stat6/ macro-
phages both in vitro and in vivo. In addition, Il-4-Stat6 suppresses
Nlrp3 inﬂammasome activation and Il-1b production by PA in LPS-
primed macrophages. Whereas M2 macrophages are thought to pro-
mote metabolic homeostasis through an anti-inﬂammatory mecha-
nism, our data indicate that the Th2 cytokine-Stat6-Ppar signaling
cascade also increases tolerance to lipid stress within WAT where
ATMs encounter ﬂuctuating FA ﬂux. Interestingly, obesity has been
shown to increase the viability of pro-inﬂammatory ATMs mediated by
NF-kB [35], suggesting that selective activation of macrophage sur-
vival program through the Stat6-Ppar axis over that of NF-kB is a
critical step to limit metabolic inﬂammation.
It has been reported that increased lipolysis either by fasting/b-
adrenergic agonists or obesity promotes macrophage inﬁltration to
WAT [1,9,14]. These ATMs accumulate TG-enriched lipid droplets
leading to a foamy morphology analogous to cholesterol-laden foam
cells in atherosclerosis [9]. In the context of obesity, ATMs are the main
source of inﬂammatory mediators, such as Mcp-1, Tnf-a and Il-1b
[1,9], implicating a role for FA-mediated metabolic stress in
Table 1 e Metabolic parameters of mouse studies.
Saline injection CL316,243 injection
WT Mac-Ppard/g/ WT Mac-Ppard/g/
Body weight (g) 31.6  1.6 29.6  1.9 30.6  1.5 30.4  1.3
WAT/body weight 0.040  0.006 0.036  0.008 0.046  0.004 0.040  0.004
Glucose (mg/dl) 141.5  13.5 136.5  12.1 72.4  2.3# 73.3  3.1#
Free FA (mmol/l) 1.03  0.11 1.02  0.12 2.23  0.24# 2.17  0.24#
TG (mg/dl) 120.3  15.8 104.8  12.8 190.0  28.2 232.8  23.9#
Insulin (ng/ml) 0.83  0.10 1.02  0.25 1.03  0.19 1.05  0.11
WT Stat6/ WT Stat6/
Body weight (g) 30.5  0.6 31.1  0.8 28.6  1.2 27.9  2.0
WAT/body weight 0.044  0.003 0.041  0.001 0.034  0.002# 0.032  0.004#
Glucose (mg/dl) 197.8  27.8 130.0  9.9 73.0  2.2# 87.8  4.6*#
Free FA (mmol/l) 1.03  0.08 1.16  0.03 1.79  0.15# 2.01  0.05#
TG (mg/dl) 103.7  4.8 110.5  7.8 156.2  20.1# 157.8  18.9
Insulin (ng/ml) 0.89  0.14 0.79  0.15 0.87  0.09 1.72  0.29*#
Values are expressed as means  SEM. *p < 0.05 between genotypes; #p < 0.05 between saline and CL316,243 injection.
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Figure 5: Increased cell death and inﬂammation triggered by lipolysis in adipose tissue macrophages from Mac-Ppard/g/ or Stat6/ mice. (AeD) Chow fed WT and
Mac-Ppard/g/ or Stat6/ mice (3-month-old males) were fasted for 14 h, followed by intraperitoneal injection of 1 mg/kg CL316,243 or saline (vehicle). Animals were
sacriﬁced 2.5 h after injection and SVF and ATMs were isolated from WAT. (A) Quantiﬁcation of caspase-3 activity in isolated ATMs. Left and right panels were from saline and
CL316,243 injection, respectively. (B) Gene expression determined by qPCR in ATMs collected from WT and Mac-Ppard/g/ mice with CL316,243 injection. (C) Quantiﬁcation of
caspase-3 activity of ATMs from WT and Stat6/ mice. (D) Gene expression in ATMs collected from WT and Stat6/ mice with CL316,243 injection. Studies were conducted in
two cohorts (n ¼ 4e7 per treatment per genotype). Values were presented as means  SEM. *p < 0.05 between WT and Mac-Ppard/g/ or Stat6/ mice. (E) Model for the
role of M2 polarization in protecting ATMs against lipotoxicity-induced cell death and metabolic inﬂammation.
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macrophage dysfunction and pro-inﬂammatory activation. Our results
suggest that a physiological function of M2 ATMs is to help alleviate
such stress (Figure 5E). Immediately downstream of Th2 cytokines is
the master M2 regulator Stat6 that directly controls mitochondrial
ﬁtness, including oxidative metabolism and pro-survival gene Bcl2,
and up-regulates Pparg and Ppard, both of which promote FA b-
oxidation and mitochondrial biogenesis. In addition, Stat6 suppresses
the expression of Nlrp3 gene. Enhanced mitochondrial function is
expected to also reduce the production of reactive oxygen species, a
stimulant of Nlrp3 inﬂammasome activation [36]. Obesity or over-
nutrition leads to deprivation of Th2 cytokine producing cells [1e3]
and enrichment of pro-inﬂammatory macrophages, which have
increased glycolytic metabolism and dampened mitochondrial function
[9,16,20]. The inability of these pro-inﬂammatory macrophages to help
relieve excess FAs within WAT likely contributes to systemic lipid
dysregulation and the chronic, unresolvable meta-inﬂammation. In
concert, studies have demonstrated that Ppar-mediated lipid meta-
bolism plays a key role in limiting inﬂammation in metabolically acti-
vated macrophages [5].
Previous studies have demonstrated that Stat6/, myeloid-Ppard/
and myeloid-Pparg/ mice are more insulin resistance due to M1
skewing of ATMs [17,20e22]. Findings from the current work indicate
that increased lipotoxicity-induced macrophage death may also
contribute to this phenotype. In support of this notion, b-adrenergic
agonist CL316,243 triggered lipolysis induces more caspase-3 activity,
accompanied by up-regulation of pro-inﬂammatory gene expression in
ATMs isolated from Mac-Ppard/g/ or Stat6/ mice (Figure 5). The
pro-survival effect is mediated by transcriptional regulation of genes
related to cell death/survival, in addition to the well-established
function of the Stat6-Ppar pathway in mitochondrial integrity and ac-
tivity. The array data reveal that pro-survival genes regulated by Ppars
and Sta6 are largely non-overlapping (Supplementary Figure 1D and
Supplementary Tables 7 and 8), although the expression of some of
those genes is similarly affected in Mac-Ppard/g/ or Stat6/
macrophages, supporting a Stat6-Ppar signaling cascade. Angptl4, a
Ppar target, inhibits TG hydrolysis thereby preventing macrophages
from lipid overload [37]. This is consistent with a previous report
suggesting that ATMs take up excess lipids and secrete anti-lipolytic
factors to reduce local free FA concentrations [14]. On the other
hand, Stat6 up-regulates Bcl2, a mitochondrial anti-apoptotic gene
[38]. The pro-survival effect of Ppars and Stat6 could also be mediated
by suppression of cell death promoting genes.
Among the cell death/survival genes, Sgms1 is a commonly regulated
gene by Ppard/g and Stat6 that reduces levels of ceramide by con-
verting it to sphingomyelin [32,33]. Ceramide synthesis is elevated by
increasing cellular FA uptake [39] and serves as a trigger for cell death
and inﬂammasome activation [1,13,15]. This may explain why deletion
and activation of Stat6/Ppars enhances and suppresses Nlrp3
inﬂammasome activation/Il-1b release, respectively. Il-4/Stat6 exhibits
a substantially stronger effect likely due to the ability of Stat6 to down-
regulate Nlrp3 expression. Stat6/ macrophages have increased
basal mitochondrial oxygen consumption (Figure 2C) and, at same
time, show more cell death in the fasted state (Figure 5C). It is possible
that the increased OCR is a compensatory response to defective
substrate metabolism (e.g., fat oxidation). In addition, the uncoupled
respiration (proton leak) is higher in Stat6/ (3.2  0.16 pMole/min/
mg), compared to WT (1.68  0.13) and Ppard/g/ (1.73  0.13)
macrophages, implicating mitochondrial dysfunction. Coupled with the
elevated Nlrp3 (Supplementary Figure 3D) that can mediate
inﬂammasome-induced cell death (pyroptosis, Figure 4C), Stat6/
ATMs would be expected to be more susceptible to cell death by
fasting-induced lipolysis.
Collectively, these observations indicate that FA-induced cell death and
inﬂammation is intimately linked. In the microenvironment of adipose
tissues where local free FA concentrations ﬂuctuate, M2 polarization
regulated by the Stat6-Ppar axis affords ATMs the metabolic capacity
to reduce lipid burden and tolerate lipotoxicity, thereby maintaining the
homeostatic state within WAT. It is worth noting that macrophages
perform diverse functions dynamically regulated by external stimuli
through multiple signaling pathways. The current study focuses on the
Stat6-Ppar axis in the context of excess lipid-induced metabolic stress
and as such, does not exclude contributions from other regulatory
mechanisms. In addition, gene deletion does not truly reﬂect a path-
ological condition. Nevertheless, gain-of-function studies using Il-4
and Ppar agonists do support a protective role for Stat6-Ppars in
free FA-mediated metabolic inﬂammation and cell death.
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